Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. (apre una nuova finestra)

Baron DM, Hochrieser H, Posch M, Metnitz B, Rhodes A, Moreno RP, Pearse RM, Metnitz P; European Surgical Outcomes Study (EuSOS) group for Trials Groups of European Society of Intensive Care Medicine; European Society of Anaesthesiology.

Fonte‎: Br J Anaesth 2014;113(3):416-23.

Indicizzato‎: PubMed 24829444

DOI‎: 10.1093/bja/aeu098

https://www.ncbi.nlm.nih.gov/pubmed/24829444 (apre una nuova finestra)

Intraoperative bleeding and haemostasis during pelvic surgery for locally advanced or recurrent rectal cancer: a prospective evaluation. (apre una nuova finestra)

Bonello VA, Bhangu A, Fitzgerald JE, Rasheed S, Tekkis P.

Fonte‎: Tech Coloproctol 2014;18(10):887-93.

Indicizzato‎: PubMed 24890577

DOI‎: 10.1007/s10151-014-1150-z

https://www.ncbi.nlm.nih.gov/pubmed/24890577 (apre una nuova finestra)

A cohort investigation of anaemia, treatment and the use of allogeneic blood transfusion in colorectal cancer surgery. (apre una nuova finestra)

Keeler BD, Mishra A, Stavrou CL, Beeby S, Simpson JA, Acheson AG.

Fonte‎: Ann Med Surg (Lond) 2016;6:6-11.

Indicizzato‎: PubMed 26909150

DOI‎: 10.1016/j.amsu.2015.12.052

https://www.ncbi.nlm.nih.gov/pubmed/26909150 (apre una nuova finestra)

The theory and practice of bloodless surgery. (apre una nuova finestra)

Martyn V, Farmer SL, Wren MN, Towler SC, Betta J, Shander A, Spence RK, Leahy MF.

Fonte‎: Transfus Apher Sci 2002;27(1):29-43.

Indicizzato‎: PubMed 12201468

https://www.ncbi.nlm.nih.gov/pubmed/12201468 (apre una nuova finestra)

Non-blood medical care in gynecologic oncology: a review and update of blood conservation management schemes. (apre una nuova finestra)

Simou M, Thomakos N, Zagouri F, Vlysmas A, Akrivos N, Zacharakis D, Papadimitriou CA, Dimopoulos MA, Rodolakis A, Antsaklis A.

Fonte‎: World J Surg Oncol 2011;9:142.

Indicizzato‎: PubMed 22051161

DOI‎: 10.1186/1477-7819-9-142

https://www.ncbi.nlm.nih.gov/pubmed/22051161 (apre una nuova finestra)

Effects of trilaciclib on chemotherapy-induced myelosuppression and patient-reported outcomes in patients with extensive-stage small cell lung cancer: Pooled results from three phase ii randomized, double-blind, placebo-controlled studies. (apre una nuova finestra)

Weiss J, Goldschmidt J, Andric Z, Dragnev KH, Gwaltney C, Skaltsa K, Pritchett Y, Antal JM, Morris SR, Daniel D

Fonte‎: Clin Lung Cancer 2021;22(5):449-60. 

Indicizzato‎: PubMed 33895103

DOI‎: 10.1016/j.cllc.2021.03.010

https://pubmed.ncbi.nlm.nih.gov/33895103/ (apre una nuova finestra)

Adverse effects on hemostatic function of drugs used in hematologic malignancies. (apre una nuova finestra)

Zakarija A, Kwaan HC.

Fonte‎: Semin Thromb Hemost 2007;33(4):355-64.

Indicizzato‎: PubMed 17525893

DOI‎: 10.1055/s-2007-976171

https://www.ncbi.nlm.nih.gov/pubmed/17525893 (apre una nuova finestra)